ArticleAmerican journal of epidemiology2026
Coexposure confounding and amplification of bias-an exploration with practical interpretation and perspectives.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Epidemiologists increasingly estimate associations between mixtures of correlated coexposures and health outcomes. We propose an exploratory approach to help differentiate coexposure confounding from coexposure amplification of bias (CAB) for studies considering correlated coexposures using a case example and simulations based on observed relationships. Our example uses associations observed in published studies between co-occurring per- and polyfluoroalkyl substance (PFAS) biomarkers and tetanus antibody concentrations but could apply to any context where statistical modeling is performed with and without inclusion of correlated coexposures. Using directed acyclic graphs (DAGs), to define an assumed causal structure, and simulations of 3 PFAS predicting antibody titers, we show that if researchers can assume 1 component in the exposure mixture is correlated with the other components, but does not cause the outcome, then CAB can be detected by testing whether the estimate for the noncausal component in a multipollutant model is different from zero. In our simulation, the estimate for the noncausal component was zero (95% CI, -0.22, 0.25) when CAB was absent and -0.25 (95% CI, -0.48, 0.00) when present. These results illustrate a possible method to identify CAB and select statistical models that may produce less biased effect estimates if our assumed DAG is correct.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.